StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$270.56−2.64 (-0.97%)

Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%

Johnson & Johnson COVID-19 Vaccine [reported through FY2024Q4] by Quarter

COVID-19 Vaccine (Ad26.COV2.S) [reported through FY2024Q4] — U.S. sales ($M) ($M)

QuarterlyAnnual

Johnson & Johnson COVID-19 Vaccine [reported through FY2024Q4]: $0M in Q4 2024. That is the lowest of the 20 quarters on record here. No newer figure appears in the documents we track.

Latest, Q4 2024
0
Period ended Dec 29, 2024
Change on a year earlier
–
0 in Q4 2023
History
20 quarters
Since Q1 2020
Sources
15
Documents cited below

Where the Q4 2024 figure comes from

Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)

Source: Form 10-K (filed 2025-02-13) ↗

Reported in Form 10-Q / 10-K Segment Note & Form 8-K EX-99.2 Segment Sales Schedule.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCOVID-19 Vaccine (Ad26.COV2.S) [reported through FY2024Q4] — U.S. sales ($M) ($M)Year on yearSource
Q4 2024Dec 29, 20240–Form 10-K (filed 2025-02-13) ↗
Q3 2024Sep 29, 20240–Form 10-Q (filed 2024-10-23) ↗
Q2 2024Jun 30, 20240–Form 10-Q (filed 2024-07-25) ↗
Q1 2024Mar 31, 20240–Form 10-Q (filed 2024-05-01) ↗
Q4 2023Dec 31, 20230–Form 10-K (filed 2025-02-13) ↗
Q3 2023Oct 1, 20230–Form 10-Q (filed 2024-10-23) ↗
Q2 2023Jul 2, 20230-100.0%Form 10-Q (filed 2024-07-25) ↗
Q1 2023Apr 2, 20230-100.0%Form 10-Q (filed 2024-05-01) ↗
Q4 2022Jan 1, 20230-100.0%Form 10-K (filed 2025-02-13) ↗
Q3 2022Oct 2, 20220-100.0%Form 10-Q (filed 2023-10-27) ↗
Q2 2022Jul 3, 202245-11.8%Form 10-Q (filed 2023-07-31) ↗
Q1 2022Apr 3, 202275-25.0%Form 10-Q (filed 2023-04-28) ↗
Q4 2021Jan 2, 2022213–Form 10-K (filed 2024-02-16) ↗
Q3 2021Oct 3, 2021270–Form 10-Q (filed 2022-10-27) ↗
Q2 2021Jul 4, 202151–Form 10-Q (filed 2022-07-29) ↗
Q1 2021Apr 4, 2021100–Form 10-Q (filed 2022-04-29) ↗

Cite this data

StockData. (2026). Johnson & Johnson COVID-19 Vaccine [reported through FY2024Q4] ($M), quarterly Q1 2020–Q4 2024 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/drug-covid19-us

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.